ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A homologous and molecular dual-targeted biomimetic nanocarrier for EGFR-related non-small cell lung cancer therapy

Xu, Bin; Zeng, Fanjun; Deng, Jialong; Yao, Lintong; Liu, Shengbo; Hou, Hengliang; Huang, Yucheng; Zhu, Hongyuan; Wu, Shaowei; Li, Qiaxuan; Zhan, Weijie; Qiu, Hongrui; Wang, Huili; Li, Yundong; Yang, Xianzhu; Cao, Ziyang*; Zhang, Yu*; Zhou, Haiyu*广东省人民医院; 广州中医药大学; 南方医科大学; 汕头大学; 1; y
Bioactive Materials2023-9DOI: 10.1016/j.bioactmat.2023.04.005
5被引13阅读
引用收藏
分享

摘要

The abnormal activation of epidermal growth factor receptor (EGFR) drives the development of non-small cell lung cancer (NSCLC). The EGFR-targeting tyrosine kinase inhibitor osimertinib is frequently used to clinically treat NSCLC and exhibits marked efficacy in patients with NSCLC who have an EGFR mutation. However, free osimertinib administration exhibits an inadequate response in vivo, with only similar to 3% patients demonstrating a complete clinical response. Consequently, we designed a biomimetic nanoparticle (CMNP@Osi) comprising a polymeric nanoparticle core and tumor cell-derived membrane-coated shell that combines membrane-mediated homologous and molecular targeting for targeted drug delivery, thereby supporting a dual-target strategy for enhancing osimertinib efficacy. After intravenous injection, CMNP@Osi accumulates at tumor sites and displays enhanced uptake into cancer cells based on homologous targeting. Osimertinib is subsequently released into the cytoplasm, where it suppresses the phosphorylation of upstream EGFR and the downstream AKT signaling pathway and inhibits the proliferation of NSCLC cells. Thus, this dual-targeting strategy using a biomimetic nanocarrier can enhance molecular-targeted drug delivery and improve clinical efficacy.

学科与关键词

关键词
Biomimetic nanoparticlesMembrane targetingEGFR mutationTyrosine kinase inhibitorIntracellular drug deliveryClinical efficacyNon -small cell lung cancer
相关
加载中…
  • An Activatable Nano-Prodrug for Treating Tyrosine-Kinase-Inhibitor-Resistant Non-Small Cell Lung Cancer and for Optoacoustic and Fluorescent Imaging
    Xie, Xin; Zhan, Chenyue; Wang, Jie; Zeng, Fang*; Wu, Shuizhu*Small, 2020, 16(38): 2003451.被引 22
  • Delivery of gefitinib with an immunostimulatory nanocarrier improves therapeutic efficacy in lung cancer
    Diao, Dingwei; Zhai, Jianxue; Yang, Jianjun; Wu, Hua; Jiang, Jianjun; Dong, Xiaoying; Passaro, Antonio; Aramini, Beatrice; Rao, Shuan*; Cai, Kaican*Translational Lung Cancer Research, 2021, 10(2): 926-935.被引 5
  • Aptamer-Functionalized ZIF-8 Nanomedicine for Targeted Delivery of Gefitinib and siRNA to Treat Tyrosine-Kinase-Inhibitor-Resistant Nonsmall-Cell Lung Cancer
    Liu, Meng; Sun, Chuanchuan; Jiang, Jiangle; Wan, Li; Hu, Chong; Wen, Chunping; Huang, Guiju; Ruan, Qiufen; Wu, Shuang; Qiao, Dan; Zheng, Pengwu; Pan, Qingshan*; Zhu, Wufu*ACS Applied Nano Materials, 2023, 6(23): 21587-21602.
查看全部 →

发表信息

论文状态
公开发表
期刊
Bioactive Materials
发表日期
2023-09
卷期
第 27 卷
页码
337-347
DOI
10.1016/j.bioactmat.2023.04.005
成果收录
SCIE
资助标注
National Key R & D Program of China [2022YFD2401900]; National Natural Science Foundation of China [52203163]; High-level Hospital Construction Project [DFJH201905]; Natural Science Foundation of Guangdong [2021A1515010838]; International Science and Technology Coop- eration Program of Guangdong [2022A0505050048]; Science and Technology Program of Guangzhou [201903010028]; Guang- dong Provincial People's Hospital Intermural Program

作者

  • X

    Xu, Bin (第一作者)

    guangdong prov peoples hosp · southern med univ

  • Z

    Zeng, Fanjun

    guangdong prov peoples hosp · southern med univ

查看全部 18 位作者收起作者
  • D

    Deng, Jialong

    guangdong prov peoples hosp · southern med univ

  • Y

    Yao, Lintong

    guangdong prov peoples hosp · southern med univ · shantou univ

  • L

    Liu, Shengbo

    guangdong prov peoples hosp · southern med univ · 2

  • H

    Hou, Hengliang

    guangdong prov peoples hosp · southern med univ

  • H

    Huang, Yucheng

    guangdong prov peoples hosp · southern med univ

  • Z

    Zhu, Hongyuan

    guangdong prov peoples hosp · southern med univ

  • W

    Wu, Shaowei

    guangdong prov peoples hosp · southern med univ · 2

  • L

    Li, Qiaxuan

    guangdong prov peoples hosp · southern med univ · shantou univ

  • Z

    Zhan, Weijie

    guangdong prov peoples hosp · southern med univ · 2

  • Q

    Qiu, Hongrui

    guangzhou univ chinese med · guangdong prov peoples hosp · southern med univ

  • W

    Wang, Huili

    guangzhou univ chinese med · guangdong prov peoples hosp · southern med univ

  • L

    Li, Yundong

    chinese acad fishery sci

  • Y

    Yang, Xianzhu

  • C

    Cao, Ziyang (通讯)

    1

  • Z

    Zhang, Yu (通讯)

    guangdong prov peoples hosp · southern med univ

  • Z

    Zhou, Haiyu (通讯)

    guangzhou univ chinese med · guangdong prov peoples hosp · southern med univ · shantou univ · 2

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417